Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer
G T Budd, P C Adamson, M Gupta, et al.
Urology
|
October 8, 1999
T-cell adoptive immunotherapy of metastatic renal cell carcinoma
G E Plautz, R M Bukowski, A C Novick, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1996
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy
T Olencki, J Finke, R Tubbs, et al.
Cancer
|
March 1, 1994
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study
R M Bukowski, C M Tangen, R F Peterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy
R M Bukowski, P Rayman, R Uzzo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 1, 1992
Pseudo-gamma heavy chain (IgG4 lambda) deposition disease
R R Tubbs, V Berkley, R Valenzuela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2006
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
T K Choueiri, Bi Rini, J A Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings
R M Bukowski, T Olencki, H Gunn, et al.
AJR. American Journal of Roentgenology
|
November 1, 1985
Magnetic resonance with marked T2-weighted images: improved demonstration of brain lesions, tumor, and edema
A S Smith, M A Weinstein, M T Modic, et al.
Journal of the National Cancer Institute
|
May 19, 1993
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy
D C Case, R M Bukowski, R W Carey, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer
G T Budd, P C Adamson, M Gupta, et al.
Urology
|
October 8, 1999
T-cell adoptive immunotherapy of metastatic renal cell carcinoma
G E Plautz, R M Bukowski, A C Novick, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
January 1, 1996
Immunomodulatory effects of interleukin-2 and interleukin-4 in patients with malignancy
T Olencki, J Finke, R Tubbs, et al.
Cancer
|
March 1, 1994
Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study
R M Bukowski, C M Tangen, R F Peterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy
R M Bukowski, P Rayman, R Uzzo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 1, 1992
Pseudo-gamma heavy chain (IgG4 lambda) deposition disease
R R Tubbs, V Berkley, R Valenzuela, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 25, 2006
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
T K Choueiri, Bi Rini, J A Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 1996
Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings
R M Bukowski, T Olencki, H Gunn, et al.
AJR. American Journal of Roentgenology
|
November 1, 1985
Magnetic resonance with marked T2-weighted images: improved demonstration of brain lesions, tumor, and edema
A S Smith, M A Weinstein, M T Modic, et al.
Journal of the National Cancer Institute
|
May 19, 1993
Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy
D C Case, R M Bukowski, R W Carey, et al.
Page
of 17